tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $-47.1. This is a potential upside of $-62.2 (-411.92%) from yesterday's end of day stock price of $15.1.
Neoleukin Therapeutics's activity chart (see below) currently has 24 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 90.28% with an average time for these price targets to be met of 453.58 days.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 09-May-2023. First documented stock forecast 17-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$7.5
$-7.6 (-50.33%)
$10
2 years 4 months 28 days ago
(09-May-2023)
3/3 (100%)
$-10.3 (-57.87%)
252
Buy
$110
2 years 10 months 21 days ago
(16-Nov-2022)
1/1 (100%)
$-130.4 (-54.24%)
584
Hold
$4.5
$-10.6 (-70.20%)
$90
2 years 10 months 22 days ago
(15-Nov-2022)
1/2 (50%)
$-4 (-47.06%)
365
Hold
$100
2 years 10 months 22 days ago
(15-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
Buy
$15
$-0.1 (-0.66%)
$90
3 years 25 days ago
(12-Sep-2022)
2/2 (100%)
$-6.4 (-29.91%)
335
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NLTX (Neoleukin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?
